This inventor holds 1 USPTO granted patent. Top assignees: Northeastern University, Shanghai Sixth People's Hospital. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Innovations by Inventor Xia Yu
Introduction
Xia Yu is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medical technology, particularly in diabetes management. His innovative approach focuses on intelligent systems that enhance patient care through advanced data interpretation.
Latest Patents
Xia Yu holds a patent for an "Ambulatory glucose profile (AGP) intelligent interpretation and insulin adjustment method based on expert system." This method involves establishing a knowledge base within an inference mechanism. It constructs an interpretation and decision support expert system with a simplified architecture based on the knowledge base. The system analyzes patient problems in three dimensions: hypoglycemia, blood glucose fluctuation, and hyperglycemia. It expands each rule with expert AGP interpretation and empirical data. Additionally, it constructs rules for basal and mealtime insulin dosage adjustments using an interval type-2 fuzzy expert system. The system adjusts nodes in the patient problem analysis tree based on interpretations and provides decision suggestions.
Career Highlights
Xia Yu has worked at prominent institutions such as Northeastern University and Shanghai Sixth People's Hospital. His work in these organizations has allowed him to develop and refine his innovative methods for diabetes management.
Collaborations
Xia Yu has collaborated with notable colleagues, including Hongru Li and Xiaoyu Sun, who have contributed to his research and development efforts.
Conclusion
Xia Yu's contributions to medical technology, particularly in diabetes management, showcase his innovative spirit and dedication to improving patient care. His patent reflects a significant advancement in the intelligent interpretation of glucose profiles, which can lead to better insulin management for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile